TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Obstructive Sleep Apnea Syndrome
Brief Summary: Hypothesis: Computer controlled continuous positive airway pressure (autoCPAP) is equally effective in improving obstructive sleep apnea syndrome symptoms, breathing disturbances, objective vigilance, and it is cost-effective compared to conventional fixed continuous positive airway pressure.


Options:
A: Arm Label: Standard Duty Hour Schedule; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Flexible Duty Hour Schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Flexible Duty Hour Schedule | Intervention Type: BEHAVIORAL; Name: Flexible Duty Hour Schedule; Assigned to Arm(s): Flexible Duty Hour Schedule
B: Arm Label: Provent; Type: ACTIVE_COMPARATOR; Interventions: Device: Provent® | Arm Label: Placebo-Provent; Type: PLACEBO_COMPARATOR; Interventions: Device: Provent®, Device: Placebo-Provent® | Arm Label: CPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Provent®, Procedure: CPAP | Intervention Type: DEVICE; Name: Provent®; Assigned to Arm(s): CPAP, Placebo-Provent, Provent | Intervention Type: DEVICE; Name: Placebo-Provent®; Assigned to Arm(s): Placebo-Provent | Intervention Type: PROCEDURE; Name: CPAP; Assigned to Arm(s): CPAP
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: constant CPAP devices | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: automatic CPAP devices | Intervention Type: DEVICE; Name: constant CPAP devices; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: automatic CPAP devices; Assigned to Arm(s): 2
D: Arm Label: Intervention cohort; Type: EXPERIMENTAL; Interventions: Other: SCS intervention schedule | Arm Label: Control cohort; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SCS intervention schedule; Assigned to Arm(s): Intervention cohort

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Obstructive Sleep Apnea Syndrome
Brief Summary: Hypothesis: Computer controlled continuous positive airway pressure (autoCPAP) is equally effective in improving obstructive sleep apnea syndrome symptoms, breathing disturbances, objective vigilance, and it is cost-effective compared to conventional fixed continuous positive airway pressure.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: constant CPAP devices | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: automatic CPAP devices | Intervention Type: DEVICE; Name: constant CPAP devices; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: automatic CPAP devices; Assigned to Arm(s): 2
B: Arm Label: Fixed CPAP; Type: EXPERIMENTAL; Interventions: Device: Fixed CPAP | Arm Label: Auto-adjusting CPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Auto-adjusting CPAP | Intervention Type: DEVICE; Name: Fixed CPAP; Assigned to Arm(s): Fixed CPAP | Intervention Type: DEVICE; Name: Auto-adjusting CPAP; Assigned to Arm(s): Auto-adjusting CPAP
C: Intervention Type: DEVICE; Name: AutoCPAP; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: FixCPAP; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: BiPap auto with Fi Flex | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard CPAP | Intervention Type: DEVICE; Name: BiPap auto with Fi Flex; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Standard CPAP; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Balloon Angioplasty Versus Stenting With Nitinol Stents in the Superficial Femoral Artery
Brief Summary: Minimal invasive treatment (called "endovascular") of the arteries of the lower limb remains problematic, because recurrent disease ("restenosis") frequently leads to recurrent symptoms. As yet, balloon angioplasty remains the recommended strategy to revascularize the superficial femoral artery (artery of the thigh). We investigated whether the use of a vascular endoprosthesis ("stent") improves patients´ outcome.

Study hypothesis: Primary stenting with self expanding nitinol stents may improve patency after endovascular treatment of superficial femoral artery obstructions compared to balloon angioplasty with optional stenting.


Options:
A: Arm Label: Drug-eluting balloon; Type: EXPERIMENTAL; Interventions: Device: Cotavance Drug-Eluting Balloon | Arm Label: Plaque excision + drug-eluting balloon; Type: EXPERIMENTAL; Interventions: Device: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon | Arm Label: Severely Ca++ Group; Type: EXPERIMENTAL; Interventions: Device: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon | Intervention Type: DEVICE; Name: Cotavance Drug-Eluting Balloon; Assigned to Arm(s): Drug-eluting balloon | Intervention Type: DEVICE; Name: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon; Assigned to Arm(s): Plaque excision + drug-eluting balloon | Intervention Type: DEVICE; Name: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon; Assigned to Arm(s): Severely Ca++ Group
B: Arm Label: Paclitaxel-coated balloon; Type: EXPERIMENTAL; Interventions: Device: CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter | Arm Label: Bare balloon; Type: PLACEBO_COMPARATOR; Interventions: Device: Bare Percutaneous Transluminal Angioplasty Balloon Catheter | Intervention Type: DEVICE; Name: CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter; Assigned to Arm(s): Paclitaxel-coated balloon | Intervention Type: DEVICE; Name: Bare Percutaneous Transluminal Angioplasty Balloon Catheter; Assigned to Arm(s): Bare balloon
C: Arm Label: Rotational Atherectomy + PES; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Rotational Atherectomy + PES | Arm Label: Standard Treatment (PES without Rotational Atherectomy); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Treatment (PES without Rotational Atherectomy) | Intervention Type: PROCEDURE; Name: Rotational Atherectomy + PES; Assigned to Arm(s): Rotational Atherectomy + PES | Intervention Type: PROCEDURE; Name: Standard Treatment (PES without Rotational Atherectomy); Assigned to Arm(s): Standard Treatment (PES without Rotational Atherectomy)
D: Intervention Type: PROCEDURE; Name: primary stenting; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome as well as those at risk of developing ARDS.


Options:
A: N/A
B: Arm Label: Mesenchymal stem cell arm; Type: EXPERIMENTAL; Interventions: Drug: Mesenchymal stem cells | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Mesenchymal stem cells; Assigned to Arm(s): Mesenchymal stem cell arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Albuterol Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Albuterol Sulfate, Procedure: Mini-Bronchoalveolar Lavage (BAL) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Mini-Bronchoalveolar Lavage (BAL), Drug: Placebo | Intervention Type: DRUG; Name: Albuterol Sulfate; Assigned to Arm(s): Albuterol Sulfate | Intervention Type: PROCEDURE; Name: Mini-Bronchoalveolar Lavage (BAL); Assigned to Arm(s): Albuterol Sulfate, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: PROCEDURE; Name: pulmonary artery catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: central venous catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fluid management; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome as well as those at risk of developing ARDS.


Options:
A: Intervention Type: PROCEDURE; Name: pulmonary artery catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: central venous catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fluid management; Assigned to Arm(s): N/A
B: Arm Label: Focal ARDS; Type: EXPERIMENTAL; Interventions: Procedure: Mechanical ventilation | Arm Label: non focal ARDS; Type: OTHER; Interventions: Procedure: Mechanical ventilation | Intervention Type: PROCEDURE; Name: Mechanical ventilation; Assigned to Arm(s): Focal ARDS, non focal ARDS
C: Arm Label: Conventional Ventilation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Lung Protective Ventilation | Arm Label: High Frequency Oscillation; Type: EXPERIMENTAL; Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator | Intervention Type: DEVICE; Name: SensorMedics 3100B High Frequency Oscillatory Ventilator; Assigned to Arm(s): High Frequency Oscillation | Intervention Type: PROCEDURE; Name: Lung Protective Ventilation; Assigned to Arm(s): Conventional Ventilation
D: Intervention Type: DEVICE; Name: High-frequency oscillation; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Conventional lung-open mechanical ventilation; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice
Brief Summary: This study will explore the possible effect of a tailored educational intervention towards general practitioners, in order to reduce inappropriate prescription patterns for elderly patients \> 70 years.


Options:
A: Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Educational intervention program; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: safety program; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Multi-Source Feedback: including self-assessment & coaching; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice
Brief Summary: This study will explore the possible effect of a tailored educational intervention towards general practitioners, in order to reduce inappropriate prescription patterns for elderly patients \> 70 years.


Options:
A: Intervention Type: PROCEDURE; Name: Screening for Tuberculosis; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: Quality Initiative in Rectal Cancer (QIRC) strategy; Assigned to Arm(s): N/A
D: Arm Label: Educational intervention; Type: EXPERIMENTAL; Interventions: Other: Educational intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational intervention; Assigned to Arm(s): Educational intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice
Brief Summary: This study will explore the possible effect of a tailored educational intervention towards general practitioners, in order to reduce inappropriate prescription patterns for elderly patients \> 70 years.


Options:
A: Intervention Type: BEHAVIORAL; Name: Self-management of chronic illness; Assigned to Arm(s): N/A
B: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
C: Intervention Type: BEHAVIORAL; Name: Opinion leader generated and endorsed evidence summaries; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: Combined Epi-GA/PCEA; Type: EXPERIMENTAL; Interventions: Procedure: Combined Epi-GA/PCEA | Arm Label: GA/PCIA; Type: ACTIVE_COMPARATOR; Interventions: Procedure: GA/PCIA | Intervention Type: PROCEDURE; Name: Combined Epi-GA/PCEA; Assigned to Arm(s): Combined Epi-GA/PCEA | Intervention Type: PROCEDURE; Name: GA/PCIA; Assigned to Arm(s): GA/PCIA
B: Arm Label: Sugammadex; Type: EXPERIMENTAL; Interventions: Drug: Sugammadex | Arm Label: Neostigmine/glycopyrrolate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Neostigmine, Drug: Glycopyrrolate | Intervention Type: DRUG; Name: Sugammadex; Assigned to Arm(s): Sugammadex | Intervention Type: DRUG; Name: Neostigmine; Assigned to Arm(s): Neostigmine/glycopyrrolate | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Neostigmine/glycopyrrolate
C: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: olanzapine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: olanzapine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol, Drug: Remifentanil | Arm Label: Bispectral Index Monitor; Type: EXPERIMENTAL; Interventions: Drug: Propofol, Drug: Remifentanil, Device: Bispectral Index Monitor | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Bispectral Index Monitor, Control | Intervention Type: DRUG; Name: Remifentanil; Assigned to Arm(s): Bispectral Index Monitor, Control | Intervention Type: DEVICE; Name: Bispectral Index Monitor; Assigned to Arm(s): Bispectral Index Monitor
B: Arm Label: BIS group; Type: EXPERIMENTAL; Interventions: Device: Bispectral Index Monitor | Arm Label: MAC Alert; Type: ACTIVE_COMPARATOR; Interventions: Device: Electronic MAC alert | Intervention Type: DEVICE; Name: Bispectral Index Monitor; Assigned to Arm(s): BIS group | Intervention Type: DEVICE; Name: Electronic MAC alert; Assigned to Arm(s): MAC Alert
C: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
D: Arm Label: anesthesia monitoring; Type: EXPERIMENTAL; Interventions: Device: bispectral index monitoring | Arm Label: no bispectral index monitoring; Type: EXPERIMENTAL; Interventions: Device: bispectral index monitoring | Intervention Type: DEVICE; Name: bispectral index monitoring; Assigned to Arm(s): anesthesia monitoring, no bispectral index monitoring

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: N/A
B: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
C: Intervention Type: DRUG; Name: Nitrous Oxide; Assigned to Arm(s): N/A
D: Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Arm Label: Propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Propofol | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: 70% Nitrous Oxide; Type: OTHER; Interventions: Other: Nitrous Oxide | Arm Label: No Nitrous Oxide; Type: OTHER; Interventions: Other: No Nitrous Oxide | Intervention Type: OTHER; Name: Nitrous Oxide; Assigned to Arm(s): 70% Nitrous Oxide | Intervention Type: OTHER; Name: No Nitrous Oxide; Assigned to Arm(s): No Nitrous Oxide
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
C: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
D: Intervention Type: DRUG; Name: Nitrous Oxide; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab (FCR) Versus Chemotherapy With Fludarabine and Cyclophosphamide (FC) Alone in Patients With Previously Untreated Chronic Lymphocytic Leukaemia
Brief Summary: This randomized phase III trial is studying fludarabine, cyclophosphamide, and rituximab to see how well they work compared to fludarabine and cyclophosphamide in treating patients with B-cell chronic lymphocytic leukemia.


Options:
A: Arm Label: Fludarabine+Cyclophosphamide+Rituximab (FCR); Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: Cyclophosphamide, Drug: Fludarabine Phosphate | Arm Label: Fludarabine+Cyclophosphamide (FC); Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Fludarabine Phosphate | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Fludarabine+Cyclophosphamide+Rituximab (FCR) | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Fludarabine+Cyclophosphamide (FC), Fludarabine+Cyclophosphamide+Rituximab (FCR) | Intervention Type: DRUG; Name: Fludarabine Phosphate; Assigned to Arm(s): Fludarabine+Cyclophosphamide (FC), Fludarabine+Cyclophosphamide+Rituximab (FCR)
B: Arm Label: Rituximab + PCI-32765; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: PCI-32765 | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab + PCI-32765 | Intervention Type: DRUG; Name: PCI-32765; Assigned to Arm(s): Rituximab + PCI-32765
C: Arm Label: Experimental: 1; Type: EXPERIMENTAL; Interventions: Drug: Lenalidomide | Arm Label: Placebo Comparator: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lenalidomide; Assigned to Arm(s): Experimental: 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Comparator: 2
D: Arm Label: ofatumumab; Type: EXPERIMENTAL; Interventions: Drug: ofatumumab | Intervention Type: DRUG; Name: ofatumumab; Assigned to Arm(s): ofatumumab

Answer: A